The opposing effects of n-3 and n-6 fatty acids - PubMed (original) (raw)
Review
The opposing effects of n-3 and n-6 fatty acids
Gerd Schmitz et al. Prog Lipid Res. 2008 Mar.
Abstract
Polyunsaturated fatty acids (PUFAs) can be classified in n-3 fatty acids and n-6 fatty acids, and in westernized diet the predominant dietary PUFAs are n-6 fatty acids. Both types of fatty acids are precursors of signaling molecules with opposing effects, that modulate membrane microdomain composition, receptor signaling and gene expression. The predominant n-6 fatty acid is arachidonic acid, which is converted to prostaglandins, leukotrienes and other lipoxygenase or cyclooxygenase products. These products are important regulators of cellular functions with inflammatory, atherogenic and prothrombotic effects. Typical n-3 fatty acids are docosahexaenoic acid and eicosapentaenoic acid, which are competitive substrates for the enzymes and products of arachidonic acid metabolism. Docosahexaenoic acid- and eicosapentaenoic acid-derived eicosanoids antagonize the pro-inflammatory effects of n-6 fatty acids. n-3 and n-6 fatty acids are ligands/modulators for the nuclear receptors NFkappaB, PPAR and SREBP-1c, which control various genes of inflammatory signaling and lipid metabolism. n-3 Fatty acids down-regulate inflammatory genes and lipid synthesis, and stimulate fatty acid degradation. In addition, the n-3/n-6 PUFA content of cell and organelle membranes, as well as membrane microdomains strongly influences membrane function and numerous cellular processes such as cell death and survival.
Similar articles
- Omega 3 - Omega 6: What is right for the liver?
El-Badry AM, Graf R, Clavien PA. El-Badry AM, et al. J Hepatol. 2007 Nov;47(5):718-25. doi: 10.1016/j.jhep.2007.08.005. Epub 2007 Sep 14. J Hepatol. 2007. PMID: 17869370 Review. - [Molecular mechanisms of action and health benefits of polyunsaturated fatty acids].
Rodríguez-Cruz M, Tovar AR, del Prado M, Torres N. Rodríguez-Cruz M, et al. Rev Invest Clin. 2005 May-Jun;57(3):457-72. Rev Invest Clin. 2005. PMID: 16187707 Review. Spanish. - Modulation of inflammatory cytokines by omega-3 fatty acids.
Kang JX, Weylandt KH. Kang JX, et al. Subcell Biochem. 2008;49:133-43. doi: 10.1007/978-1-4020-8831-5_5. Subcell Biochem. 2008. PMID: 18751910 Review. - Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids.
Adkins Y, Kelley DS. Adkins Y, et al. J Nutr Biochem. 2010 Sep;21(9):781-92. doi: 10.1016/j.jnutbio.2009.12.004. Epub 2010 Apr 10. J Nutr Biochem. 2010. PMID: 20382009 Review. - Fatty acid facts, Part III: Cardiovascular disease, or, a fish diet is not fishy.
Pauwels EK, Kostkiewicz M. Pauwels EK, et al. Drug News Perspect. 2008 Dec;21(10):552-61. doi: 10.1358/dnp.2008.21.10.1314058. Drug News Perspect. 2008. PMID: 19221636 Review.
Cited by
- Maternal High Linoleic Acid Alters Placental Fatty Acid Composition.
Shrestha N, Holland OJ, Kent NL, Perkins AV, McAinch AJ, Cuffe JSM, Hryciw DH. Shrestha N, et al. Nutrients. 2020 Jul 23;12(8):2183. doi: 10.3390/nu12082183. Nutrients. 2020. PMID: 32717842 Free PMC article. - Effect of ω-3 Polyunsaturated Fatty Acids-Derived Bioactive Lipids on Metabolic Disorders.
Duan J, Song Y, Zhang X, Wang C. Duan J, et al. Front Physiol. 2021 May 25;12:646491. doi: 10.3389/fphys.2021.646491. eCollection 2021. Front Physiol. 2021. PMID: 34113260 Free PMC article. Review. - Association between phthalate exposure and lower handgrip strength in an elderly population: a repeated-measures study.
Kim KN, Lee MR, Choi YH, Hwang H, Oh SY, Park C, Hong YC. Kim KN, et al. Environ Health. 2016 Aug 31;15(1):93. doi: 10.1186/s12940-016-0176-2. Environ Health. 2016. PMID: 27581612 Free PMC article. - Evaluating the appropriate oral lipid tolerance test model for investigating plasma triglyceride elevation in mice.
Ochiai M. Ochiai M. PLoS One. 2020 Oct 6;15(10):e0235875. doi: 10.1371/journal.pone.0235875. eCollection 2020. PLoS One. 2020. PMID: 33022003 Free PMC article. - Chemical Characterization and Beneficial Effects of Walnut Oil on a Drosophila melanogaster Model of Parkinson's Disease.
Avallone R, Rustichelli C, Filaferro M, Vitale G. Avallone R, et al. Molecules. 2024 Sep 4;29(17):4190. doi: 10.3390/molecules29174190. Molecules. 2024. PMID: 39275038 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources